CONTENTS

Issue 96 | July 2020

In association with

WHo?

A look back at the trials and tribulations of the World Health Organization

RECOVERY

The worlds largest clinical trial is currently underway in the UK 

Clinical trials

How can researchers salvage clinical trials following the disruption of Covid-19?

Regulation

Intellectual property has become a bit of a grey area in pursuit of Covid-19 treatments 

drug development

Can drug manufacturers keep up with the evolving nature of seasonal allergies?

Biologics

Research groups are tackling the problem of biological drug delivery in novel ways

BBB

The blood-brain barrier presents a unique challenge for drug devlivery 

immunotherapy 

Charting key immunotherapy developments in recent years  

data

Five best-practice tips for creating  and maintaining a strong data footing for AI

Comment

Why aren’t more companies automating pharmacovigilance data capture?

IMDP

Turning attention towards patient benefits with IDMP data standards implementation

02/23/2024 22:21:06
  • Home | Breaking the Barrier
  • In this issue
  • NSF
  • Contents
  • Almac
  • News
  • VEGA Company Insight
  • VEGA Australia
  • Covid-19 executive briefing by GlobalData
  • Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in
  • Covid-19’s impact on trial PROs, other endpoints can be addressed via data stratification, sensitivity analysis
  • ILC Dover
  • Vitamin D affects Covid-19 mortality
  • Clinical trial disruption due to Covid-19 has begun to slow
  • Covid-19 boosts big bio/pharma drug sales but Regeneron may be falling short
  • Mimotopes
  • The pharma industry briefing
  • Charting the ups and downs of the World Health Organization
  • Road to RECOVERY: a deep dive into the world’s largest Covid-19 drug trial
  • Salvaging clinical trials in the time of Covid-19
  • Intellectual property in the time of Covid-19
  • Molnár-Institute Company Insight
  • Molnar-Institute
  • A plight for sore eyes: the latest developments in seasonal allergy treatment
  • How research groups are tackling the problem of biologic drug delivery
  • Breaking the blood-brain barrier: neurology’s greatest challenge
  • Timeline: charting the history of immunotherapy, cancer treatment's fourth pillar
  • Creating a sure data footing for AI
  • Koehler eClinical
  • Deals in brief powered by GlobalData
  • The key list powered by GlobalData
  • Global markets and indices powered by GlobalData
  • Macro-economic indicators (1 of 2) powered by GlobalData
  • Macro-economic indicators (2 of 2) powered by GlobalData
  • Events
  • Next issue
06/25/2020 00:00:00